Evidence map›Paper›PMID 42467462›Full record

ArticleGenetics2026

Solving the mechanism of Notch activation: a geneticist's perspective.

Iva Greenwald

Abstract read
In one paragraph

Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Iva GreenwaldDepartment of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, New York, NY 10027, United States.ORCID 0000-0001-7180-3706

Funding

Regulatory Circuitry and Mechanisms Controlling Cell Fate in C. elegansR35GM131746 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Iva S Greenwald · 2019 to 2026
$5.0M
NIGMS NIH HHS R35 GM131746NIGMS NIH HHS R35GM131746
6 · The paper itself

Abstract

Notch mediates cell fate decisions in development and tissue homeostasis and can act as an oncogene or a tumor suppressor depending on the cell context. In my first essay for the GENETICS Perspectives series, "Notch and the Awesome Power of Genetics," I gave my perspective on developments in the field in the 20th century, from the isolation of the eponymous Notch mutations in Drosophila through the elucidation of the mechanism of signal transduction. That essay had a bildungsroman quality about it because the burgeoning of the Notch field and the increasing impact of Caenorhabditis elegans as a model organism coincided with my development as a scientist. But the "awesome power of genetics" was the guiding star of the essay because genetic approaches were largely responsible for identifying the core components of the signaling system and for deducing the novel cleavage mechanism by which Notch transduces signals. In this sequel, I offer my perspective as a geneticist on how the awesome power of genetics continued to have a starring role in the mechanistic discoveries that followed during the first quarter of the 21st century. I aim to show how genetics remains essential both in posing questions and in answering them even as the molecular events associated with activation of Notch signal transduction continue to be elucidated in exquisite structural detail.

Indexed as

GeneticsReceptors, NotchAnimalsCaenorhabditis elegansDrosophila ProteinsHistory, 20th CenturyHumansSignal TransductionDrosophila ProteinsReceptors, NotchADAM10DeltaDSLgamma-secretaselin-12NotchPresenilinSynNotch

Identifiers

PMID42467462
PMCPMC13450007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.